A Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects

NCT02957448 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Atherothrombotic Diseases

Interventions

DRUG: BMS 986141
DRUG: Rifampin

Sponsor

Bristol-Myers Squibb